Clinical trial Recruiting at 1 site Observational Ages 18 and up

Imaging for personalized treatment of head and neck cancer

Official title: The EMINENCE Study - PET/MR Imaging of Head Neck Cancer

Run by Norwegian University of Science and Technology · NCT04612075 · Data updated 2026-11-12

This study is testing if using advanced imaging techniques can help personalize radiotherapy for people with head and neck cancer to improve their treatment results and reduce side effects.

More Head and Neck Neoplasms trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment390 (estimated)
SponsorNorwegian University of Science and Technology
Academic / other
Drugs / interventionschemotherapy
Locations2 sites (Tromsø and 1 other locations)
StatusRecruiting
StartedJanuary 12, 2021
Main results expectedDecember 31, 2025
Study endsDecember 2028
Registry record updatedApril 14, 2026
Trial IDNCT04612075 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients with histologically confirmed locally advanced squamous cell carcinoma in the head and neck region who are scheduled for definitive radiotherapy.

Probably not a fit

Patients with general contraindications for MRI or serious comorbidities may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on improving radiotherapy for head and neck cancers by utilizing advanced imaging techniques, specifically PET and MRI. By capturing images before and during treatment, the study aims to quantify intratumoral characteristics such as oxygenation and metabolism, which can help tailor radiotherapy to individual patient needs. The goal is to establish a clinical workflow that enhances the precision of radiotherapy, potentially leading to better treatment outcomes and fewer side effects for patients. The study will also explore the integration of proton therapy as a future treatment option.

Why it matters

Potential benefit: If successful, this approach could lead to more personalized and effective radiotherapy for head and neck cancer patients, improving their outcomes and quality of life.

How similar studies have gone: Other studies utilizing advanced imaging techniques for personalized radiotherapy have shown promising results, indicating potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* willing and able to give full written consent according to the protocol approved by the Regional Ethics Committee
* histologically confirmed squamous cell carcinoma in the head neck region (pharynx, larynx, oral cavity or sinonasal area)
* locally advanced disease without sign of dissemination (T3/T4 and/or N1-3, M0) on diagnostic imaging
* scheduled for definitive radiotherapy with curative intent with or without concomitant chemotherapy
* adequate renal function: Creatinine clearance ≥ 60 ml/minute
* lymph node metastasis from cancer of unknown primary of the upper neck (i.e. level II-III) were PET/CT is negative outside the head-neck region can be considered for inclusion at the discretion of the study investigators.

Exclusion Criteria:

* general contraindications for MRI (pacemaker, aneurysm clips, any form of metal in the body, severe claustrophobia)
* serious comorbidity (including previous or othe cancer) that in the opinion of the investigator would compromise the patient's ability to complete the study of interfere with the evaluation of the study objectives (e.g. poorly controlled diabetes mellitus)
* histologically confirmed SCC of same or other origin within the last five years
* patient wants to withdraw for any reason during the study

Where it's running

  • St Olavs Hospital, Department of Oncology
    Trondheim, Norway
    Recruiting
  • University Hospital of North Norway
    Tromsø, Norway
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.